Skip to content
ETopical – Lifestyle
Author:
Blue Lake Biotechnology
Blue Lake Biotechnology Secures $5 Million Grant to Support Ongoing Pediatric Phase 1/2a Clinical Trial of Intranasal RSV Vaccine Candidate
October 28, 2026